Related Experiment Videos
Hematogenous osteomyelitis in children
Insights
Hematogenous osteomyelitis in children, often caused by Staphylococcus aureus, requires prolonged antibiotic treatment (≥6 weeks). Surgical intervention is recommended for severe cases or when pus forms to prevent complications like growth disturbances.
Area of Science:
- Pediatric Infectious Diseases
- Orthopedic Surgery
- Microbiology
Background:
- Hematogenous osteomyelitis is a serious bone infection in children.
- Staphylococcus aureus is the predominant pathogen identified.
- Treatment strategies involve antibiotics and, in some cases, surgical intervention.
Purpose of the Study:
- To evaluate treatment outcomes for pediatric hematogenous osteomyelitis.
- To identify factors influencing recurrence and long-term complications.
- To provide evidence-based recommendations for antibiotic therapy and surgical management.
Main Methods:
- Retrospective analysis of 31 children treated over 10 years.
- Review of treatment approaches (open vs. closed), culture results, and antibiotic regimens.
- Assessment of patient outcomes including recurrences and growth disturbances at long-term follow-up.
Main Results:
- Staphylococcus aureus was identified in 13 of 14 positive cultures.
- Three recurrences suggested potential benefit from more aggressive primary treatment.
- Three neonates experienced severe growth disturbances despite optimal initial management.
- Antibiotic therapy of 6 weeks or longer yielded acceptable results.
Conclusions:
- Prolonged antibiotic therapy (≥6 weeks) is effective for hematogenous osteomyelitis.
- Surgical intervention is indicated for abscess formation or lack of improvement with conservative management.
- Early and aggressive treatment may reduce the risk of recurrence and long-term sequelae.
Abstract:
In a 10-year period, 31 children, including 9 infants, were treated for hematogenous osteomyelitis. Fifteen children were treated closed and 16 open. Thirteen of 14 positive cultures were Staphylococcus aureus. Three recurrences could possibly have been prevented by a more aggressive primary approach. At follow-up after 5 (1-12) years, 3 neonates had developed severe growth disturbances despite optimal initial treatment. Acceptable results were obtained with antibiotic therapy for 6 weeks or more. We recommend ampicillin and a penicillinase-resistant penicillin, unless bacterial resistance patterns indicate a different antibiotic. We operate if pus has formed and if a child with severe symptoms does not improve during adequate antibiotic treatment and immobilization.